Appearance of fibronectin during the differentiation of cartilage, bone, and bone marrow by unknown
Appearance of Fibronectin during the
Differentiation of Cartilage, Bone,
and Bone Marrow
630
ROY E. WEISS and A. H. REDDI
Laboratory of Biological Structure, National Institute of Dental Research, National Institutes of Health,
Bethesda, Maryland 20205. Dr. Weiss's present address is the Department of Orthopedics, University of
Southern California Medical School, Los Angeles, California 90007.
ABSTRACT
￿
Fibronectin has been localized by indirect immunofluorescence during the various
phases of endochondral bone formation in response to subcutaneously implanted demineral-
ized bone matrix . Its histologic appearance has been correlated with results of biosynthetic
experiments . (a) The implanted collagenous bone matrix was coated with fibronectin before
and during mesenchymal cell proliferation . (b) During proliferation of mesenchymal precursor
cells, the newly synthesized extracellular matrix exhibited a fibrillar network of fibronectin . (c)
During cartilage differentiation, the fibronectin in the extracellular matrix was apparently
masked by proteoglycans, as judged by hyaluronidase treatment . (d) Differentiating chondro-
cytes exhibited a uniform distribution of fibronectin . (e) Fibronectin was present in a cottony
array around osteoblasts during osteogenesis . ( f) The developing hematopoietic colonies
revealed fibronectin associated with them . Therefore, it appears that fibronectin is ubiquitous
throughout the development of endochondral bone and bone marrow .
Fibronectin is a cell surface glycoprotein involved in cell-
substratum (usually collagen) interaction (7, 9, 11, 16, 22, 27).
A structurally related and immunologically cross-reactive pro-
tein, plasma fibronectin, is present in the blood plasma and
was previously known as cold insoluble globulin (26) . Although
many studies have investigated the involvement of fibronectin
in cell attachment in vitro (for review see reference 27), impor-
tant questions regarding its in vivo function remain, as yet,
unanswered. In particular, the role that fibronectin plays in the
development of various connective and skeletal tissues is un-
known . We have previously shown that fibronectin is synthe-
sized throughout the development of endochondral bone and
that its synthesis is maximal during mesenchymal precursor
cell proliferation and hematopoiesis (24) . However, the locali-
zation offibronectin in the developing bone and bone marrow
is not known . To study this problem, we have used an in vivo
matrix-induced endochondral bone-forming system (18-20)
and extended our earlier observations (24). In response to
subcutaneous implantation ofdemineralized collagenous bone
matrix, a cascade of events ensues starting with proliferation of
mesenchymal precursor cells at 3 d after implantation, chon-
drogenesis on day7, followed by chondrolysis with calcification
of cartilage and culminating in osteogenesis on day 10, and
hematopoiesis 21 d after implantation . Therefore, by the use of
this in vivo system, the sequential development of bone from
mesenchymal precursor cells can be studied. This study de-
scribes the localization of fibronectin by indirect immunoflu-
orescence during differentiation of cartilage, bone, and bone
marrow.
MATERIALS AND METHODS
Matrix and Implantation
Demineralized bone matrix prepared from rat diaphyses (18-20) was im-
planted subcutaneously into 28-31-d-old (120-140g) rats of Long-Evans strain .
The day of implantation was designated as day 0 . Animals were killed by CO2
asphyxiation and tissues were removed at various days during the development
ofthe bone plaque .
Protein Labeling and Extraction
Plaques at different stages of development were excised and minced into
pieces not <I mm' and incubated in 4 ml of Dulbecco's Modified Eagle's
Medium containing 25mM HEPES, 4.0 mM r.-glutamine, 5.6mM glucose, and
1.0 mM sodium pyruvate without methionine (Grand Island Biological Co.,
Grand Island, New York) for 15 min . The medium was replaced with fresh
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bated for 3 h at 37° C . This method ensured that there would be no possible
adsorption of any labeled fibronectin from circulating plasma .
After 3 h of incubation, the tissue was removed from the medium and
extracted (24). Plaque tissues were homogenized in 5 vol of50mM Tris-HCI, 20
mM Na2HP04,pH 7.4, containing0.25% Triton X-100 and a mixture ofprotease
inhibitors (50mM EDTA, 5 mM benzamidine, 0.1 M6-aminohexanoic acid, 0.5
mM phenylmethyLsulfonylfluoride (PMSF]) . Thehomogenate was then stirred at
4°Cfor4handcentrifuged at 20,000gfor20 min.The precipitate wasreextracted
three times in the above medium . The supernates were pooled and dialyzed
against deionized H2O at 4°C. The precipitate was then extracted in 4.0 M
guanidine-HCI, 50mM Tris-HCI, 20mM Na2 HP04, pH 7.4, containing 0.25%
Triton X-100 with the proteaseinhibitor mixture described above. Subsequently,
a final extraction was carried out at 4°C in 4.0 M guanidine-HCI, 50 mM
Na2C03, protease inhibitor mixture, pH 11 .0, with 0.25% Triton X-100 . More
than 90% of the total radioactivity is recovered by this sequential method of
extraction (24) . The extracts were then dialyzed against H2Oand lyophilized .
Gel Electrophoresis and Fluorography
Gelelectrophoresis (5% polyacrylamide with 0.1%SDS) was performed using
vertical slab gels (l .5-mm thick) (12). Samples were heated in a boiling water
bath for 5 min with 0.1 M ,B-mercaptoethanol, 0.1% SDS, and glycine/Tris
electrode buffer,pH 8.8. Asample containing 50-100 jig ofprotein with 200,000
cpm of each sample was applied to each well . Fluorography was performed
according to a modified procedure of Laskey and Mills (13) . Gels were fixed in
TCA 10% (wt/vol), glacial acetic acid 10% (vol/vol), methanol 30% (vol/vol),
and impregnated with EN 3HANCER (New England Nuclear, Boston, Mass .) .
Fibronectin was identified in the gels by its (a) comigration with rat and
human plasma fibronectin, (b) cross reactivity with purified antibody to rat
plasma fibronectin, (c) affinity for gelatin, and (d) insensitivity to collagenase
digestion (24) .
Preparation of Antibody to Rat
Plasma Fibronectin
ISOLATIONOF RATPLASMA FIBRONECTIN :
￿
Swineskin gelatin (Sigma Chemical
Co., St. Louis,Mo.) was coupled to Sepharose 4B (Pharmacia Fine Chemicals,
Piscataway,N . J.) at 56°C in 1.0 M NaCl,0.5 MH3BO3 ,pH 9.0, to prepare the
gelatin-Sepharose affinity column (6). The Sepharose 4B was activated by
pretreating with CNBr (3) . Freshly obtained rat plasma, with EDTA as an
anticoagulant, was chilled on ice immediately after exsanguination and then
applied to the gelatin-Sepharose column (4 x 25 cm; 75 ml of plasma) . The
columnwaswashed with 5 vol of 1.0Murea,0.05MTris-HCl, 0.02MNaH2PO,,
0.15MNaCl,0.5mM PMSF. Fibronectin was eluted with two-column volumes
of4.0Murea, 0.02MNaH2PO,, 0.15MNaCl, 0.05MTris-HCI, 0.5mM PMSF .
All chromatography was performed at 4°C . The4.0M urea wash of the gelatin-
Sepharose affinity column was dialyzed against distilled water at 4°C and then
lyophilized .
PRODUCTION OF THE ANTISERUM: The lyophilized preparation above was
treated for 5min in a boiling water bath in the following sample buffer: 0.1 M
,B-mercaptoethanoL 0.1% SDS, 1.0% glycerol, glycine/Tris-HCI electrode buffer,
pH 8.5, and then subjected to preparative5% polyacrylamide gel electrophoresis
with 0.1% SDS. Gel slices containing fibronectin were then homogenized with
incomplete Freund's adjuvant and injected into male New Zealand rabbits .
Booster injections were given 2 and 4wk later.
ISOLATION OF PURIFIED ANTIFIBRONECTIN ANTIBODIES:
￿
The lyophilized 4.0
M urea eluate, containing the fibronectin, was further purified by preparative
electrophoresis. This purified fibronectin, from the gelatin-Sepharose column,
was coupled to CNBr-activated Sepharose 4B at 4°C in 0.5 M H3B03 1.0 M
NaCl for 15 h with gentle agitation. The antiserum (20 ml)was applied to the
fibronectin-Sepharose affinity column (1 .5 x 12 cm) at 4°C . The column was
washed with buffer containing 0.002% sodium azide, 0.05M Tris-HCI, 0.15M
NaCl, pH 7.5. The eluent was monitored for protein by absorbance at 280 nm .
The fibronectin-specific antibody was eluted with 3.0 M KSCN, 0.02 M
NaH2PO4, pH 6.0 . The antibody was then immediately dialyzed against 0.02M
NaH2PG4, 0.15MNaCl (phosphate-buffered saline [PBS]) at 4°C . The fibronec-
tin monospecific antibodies did not cross react with types I and II collagens,
albumin, or fibrin, as determined by inlmunodiffusions . There was weak cross
reactivity with plasma fibronectins of human, chicken, and horse .
Enzyme-linked Immunoabsorbant Assay [ELISA]
Fibronectin was quantitated in tissue extracts and tissue culture medium by
an ELISA assay. The procedure used was similar to that described by Rennard
et al. (21) andVuento and Vaheri (23) . Immulon micro-ELISA plates (Dynatech
Corp., Alexandria, Va .) were coated with 100-200 ng of purified rat plasma
fibronectin/well . The tissue extract was incubated with the purified rabbit
antibody to rat plasma fibronectin for 60 min in PBS with 0.05% Tween 20 . The
soluble antigen-antibody mixture was then placed in the micro-ELISA wells and
incubated for 60 min. After washing, peroxidase-conjugated anti-rabbit IgG
made in goat (Miles Laboratories, Inc., Elkhart, Ind.)wasplaced in the wells for
60 min . After washing, a substrate solution containing H202 and o-phenylenedi-
amine was added . The reaction was stopped with 8.0 M H2S04 and the optical
density read at 480nm.Astandard curve was prepared atthe time ofeach assay .
Theamount offibronectin was reported perunit protein by the method ofLowry
et al . (14) .
FIGURE 1
￿
Fluorograph of 5% SDS polyacrylamide slab gel electro-
phoretogram under reducing conditions. Samples were extracted
with 20 mM Na2HP04, 50 mM Tris-HCI, 0.25% Triton X-100, pH 7.4,
containing a mixture of protease inhibitors (cf . Materials and Meth-
ods) . The arrow on the upper right indicates where purified rat
fibronectin migrates in this gel system . Note the absence of labeled
fibronectin on day 1 . The amount of fibronectin synthesized on
days 7 and 11 appears diminished .
TABLE I
ELISA Measurement of Accumulated Fibronectin during
Endochondral Bone Formation
Day of devel-
opment
TABLE II
Fibronectin lag/mg
protein
Major Phases of Matrix-induced Endochondral Bone and Bone
Marrow Development
Stage of development and cell phenotype
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1 Cell attachment
3 Mesenchymal cell proliferation
5 Chondrogenesis
7 Cartilage formation
9 Calcified cartilage, Vascular invasion
10-12 Bone formation
12-18 Bone remodeling
21 Bone marrow formation
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Day Stages
Tris/P04
extract
Guanidine,
4.0 M
extract
3 Mesenchymal proliferation 4.57 8.58
7 Chondrogenesis 20.91 12.47
12 Osteogenesis 4.00 2.18FIGUREs 2-9
￿
Frozen sections of unfixed developing plaques stained with affinity-purified rabbit anti-rat plasma fibronectin and
FITC-conjugated goat anti-rabbit IgG . B, Demineralized bone matrix that was implanted on day 0 ; M, extracellular matrix .
Negligible background fluorescence was observed in control sections stained with preimmune normal rabbit serum . Fig . 2 shows
a demineralized bone matrix 3 d after implantation . Note the appearance of fibronectin in a fibrillar orientation on the matrix
pieces (arrow) . Inset, day 0, matrix particle before implantation reveals no fibronectin associated with it . Fig . 3 shows day 1, 24 h
after implantation . Note the fibronectin coating the matrix particles (arrows) . Fig . 4 shows day 3, most of this mesenchymal cell
matrix is reactive for fibronectin . Fig . 5 shows day 5, the intensity of the staining has decreased in the extracellular matrix . Fig . 6
shows day 7, this typical cartilaginous matrix reveals fibronectin associated with the chondrocytes but absent from the extracellular
matrix . Areas that are undergoing chondrolysis reveal fibronectin in the immediate vicinity (arrow) . Fig . 7 shows day 9, extensive
chondrolysis has occurred and endosteal surfaces are seen ; fibronectin is localized around the periphery of the hypertrophic
chondrocytes (arrows) . Fig . 8 shows day 14, osteogenesis is in progress and osteoblasts (arrow), which line the endosteal surface,
have a characteristic cottony fibrillar distribution of fibronectin . Fig . 9shows day 21, hematopoiesis is evident and thebone marrow
is reactive for fibronectin (arrow); BO, newly formed bone . Bar, 25 [Lm . x 400 .
Immunofluorescence Staining
￿
thick) were cut in a cryostat at -20 °C within 3 h ofautopsy. Sections ofunfixed
matrix were incubated for 30 min at 22 °C with the affinity-purified antifibronec
Tissues were immediately placed on dry ice (-70°C) and then frozen, unfixed,
￿
tin . The protein concentration of the antibody solution was 20 ttg/ml, as deter-
in O.C.T. embedding medium (Miles Laboratories, Inc .) . Frozen sections (6-11m
￿
mined by the method of Lowry et al. (14). After incubation, the sections were
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incubated for 30 min at 22°C with fluorescein isothiocyanate (FITC)-conjugated
goat antibodies to rabbit IgG (diluted 1:20 with PBS ; Miles Laboratories, Inc.) .
A control was observed for each day of a sampling by using preimmune rabbit
sera as the first incubating solution. Another control consisted of preabsorbing
the antibody with purified antigen which yielded no fluorescence .
Enzymatic and EDTA Treatment of Sections
Frozen sections were treated for 30 min at 22°C with a I mg enzyme/ml PBS,
pH 7.5, solution ofthe following: testicularhyaluronidase (Sigma Chemical Co .),
leech hyaluronidase (Biotrics, Inc., Boston, Mass.), streptomyces hyaluronidase
(Calbiochem-Behring Corp ., American Hoechst Corp ., San Diego, Calif.), and
pronase (Calbiochem-Behring Corp .) . The slides were then washed three times
for 5 min each in PBS, air dried, and then stained for fibronectin as described
above . After each digestion, a control section was observed by using preimmune
rabbit sera as the first incubating solution . There were no qualitative differences
in the fibronectin staining between the different hyaluronidases . Enzymatic
treatment did not result in autofluorescence . Sections of tissues from day 9
through day 18 (during osteogenesis) were demineralized with 0.5 MEDTA,0.05
MTris-HCI, pH 7.4, for 1 .5 h at 22°C . Demineralized sections were then stained
for fibronectin and revealed no increase or diminution of staining.
RESULTS
A fluorograph of the electrophoretic fractionation of proteins
extracted at various stages during endochondral bone forma-
tion in Tris/PO 4/Triton buffer, pH 7.4, (>70% of the radioac-
tivity was extracted) is shown in Fig. 1 . The radiolabeled
ffbronectin was present on all days except day 1 (24 h after
implantation) . It should be noted that a Coomassie Blue-
stained gel (not shown) revealed that ffbronectin was present
on day 1, but the fluorograph indicated that it was not synthe-
sized during the pulse . The ffbronectin band was faint on days
7 and 11 . This band, as seen on days 3-14, was collagenase
insensitive, comigrated with rat and human plasma ffbronec-
tins, and stained with purified antibody to rat plasma ffbronec-
tin and bound to gelatin . Therefore, ffbronectin was synthe-
sized throughout the development ofthe plaque . 10-18% of the
newly synthesized fibronectin was extracted in the 4.0 M
guanidinepH 7.4 buffer . It is likely that this might represent a
second pool of tissue fibronectin .
To quantify total ffbronectin accumulating in the implants,
we conducted ELISA assays on extracts of tissues at various
days of development (Table I) . The data obtained from this
analysis do not directly indicate the amount synthesized but
rather the total amount accumulated in the tissue. For both
extractions shown in Table 1, day-7 tissue (i.e ., cartilage) ac-
cumulated the most fibronectin and accounted for 2% of the
total protein extracted in Tris/P0 4 . The decrease in ffbronectin
per milligram of protein seen in day-12 plaques (osteogenesis)
may be indicative of decreased fibronectin synthesis relative to
other proteins or increased degradation occurring during chon-
drolysis .
The major phases ofmatrix-induced endochondral bone and
bone marrow development is summarized in Table 11. Immu-
nofluorescence staining of the bone matrix before implantation
showed no reaction for the presence of ffbronectin (Fig . 2,
insert) . It was previously shown (24) that no detectable ffbro-
nectin could be released from the matrix after treatment with
8.0 M urea . Within 24 h of implantation, the matrix was
strongly reactive for ffbronectin-especially around the periph-
ery of the matrix particle (Fig . 3, arrow) . The source of the
ffbronectin in day-1 tissue is the circulating form, based on the
fact that it was not synthesized in situ and that matrix particles
can bind ffbronectin in vitro (24) . 3 d after implantation,
mesenchymal precursor cells proliferated and the extracellular
matrix was highly reactive for ffbronectin (Fig. 4). Observation
of the implanted, demineralized matrix revealed a ffbrillar
orientation of the ffbronectin on the matrix particles (Fig . 2,
arrow) . On day 5, chondroblasts appeared and the matrix
remained positive for ffbronectin, but the staining was dimin-
ished in intensity (Fig. 5) . By day 7, a typical cartilaginous
matrix was evident . Differentiating chondrocytes stained for
ffbronectin but the extracellular matrix was devoid of fluores-
cence (Fig. 6) . On day 9, chondrolysis occurred with the onset
of cartilage calcification . In contrast to differentiating chondro-
cytes, which have ffbronectin uniformly over their surface,
hypertrophic chondrocytes have ffbronectin localized around
their periphery (Fig . 7) . In areas ofchondrolysis, where endog-
enous hyaluronidases and/or proteases were presumably ac-
tive, fluorescence was seen, suggesting the apparent unmasking
of fibronectin (Fig. 5, arrow) . By day 11, further chondrolysis
was evident and fibronectin was observed coating endosteal
surfaces . On day 14, osteoblasts in apposition to the implanted
matrix were reactive for ffbronectin (Fig . 8, arrow) . On day 21,
although bone showed slight reactivity, the hematopoietic col-
onies indicated the presence of ffbronectin (Fig. 9) .
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the cartilaginous matrix on day 7 was a result of possible
masking of the fibronectin by proteoglycans or whether, in
fact, fibronectin was absent, we treated sections with leech,
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fungal, and bovine testicular hyaluronidases . As shown in Fig.
10, the fibronectin in a day-7 plaque was associated with the
chondrocytes but absent from the matrix. However, upon
treatment of the section with hyaluronidase, the fibronectin in
the matrix was stained (Fig. 11).A similar pattern was observed
irrespective ofthe source ofthe hyaluronidase . It is also noted
that upon treatment with hyaluronidase the cell-associated
fluorescence was lost, possibly because of contaminating pro-
teases inthe hyaluronidase preparations. The loss offibronectin
staining was not caused by cell loss because chondrocytes were
still present in the matrix, as observed with toluidine blue
staining . Treatment of the sections with pronase eliminated all
detectable fibronectin, supporting the sensitivity of cell-asso-
ciated fibronectin to proteases (Fig . 12) .No staining ofcartilage
was observed when monospecific antifibronectin was preab-
sorbed on a fibronectin affinity column (Fig. 12 a).
Because we found that hyaluronidase treatment unmasked
cartilage matrix fibronectin, the localization of fibronectin was
attempted in articular cartilage of young rats. Antibody stain-
ing showed high reactivity for fibronectin in the perichondrium
and proliferating chondrocytes (Fig. 13) . The extracellular
matrix was not reactive but, after hyaluronidase pretreatment,
fluorescence was present (Fig. 14) . Treatment of articular
cartilage sections with pronase completely abolished fluores-
cence as a result of fibronectin (Fig. 15).
In contrast to the development ofendochondral bone by the
matrix-induced system, in the epiphyseal growth plate the
events of endochondral osteogenesis occur in a continuum . A
section of the epiphyseal growth plate treated with hyaluron-
diase and stained for fibronectin is shown in Fig . 16 . The same
patterns of fibronectin distribution are observed as were de-
scribed for the matrix-induced bone forming system . Hyalu-
ronidase unmasked the cartilaginous matrix fibronectin . Hy-
pertrophic chondrocytes accumulated ffbronectm in the cell
periphery. The transverse septa of the hypertrophic zone were
positive for fibronectin. In the endosteal surfaces of the spongy
bone of an untreated section, fibronectin was seen in a typical
lacy network (Fig . 17) .
DISCUSSION
Fibronectin was synthesized during the various stages of ma-
trix-induced endochondral bone formation . Fibronectin was
also localized by immunofluorescence and was ubiquitous
throughout the development of bone . Particularly significant
was the apparent masking of fibronectin by cartilage proteo-
glycans . By day 5,when condroblasts were beginning to differ-
FIGURES 10-12 Effect of hyaluronidase and pronase treatment of
frozen sections of day 7 plaques stained for fibronectin . B, implanted
bone matrix . Fig . 10 shows the untreated control . The fibronectin is
localized within the chondrocytes (arrows) but absent in the carti-
laginous matrix. Fig . 11 shows the section treated with 25 pl of 1
mg/ml of testicular hyaluronidase in PBS, pH 7 .4, at 22°C for 30 min .
Note the appearance of fibronectin in the extracellular matrix and
the accumulation of fibronectin at the periphery of the chondro-
cytes (arrows) . Fig . 12 shows the section treated with 25 JAI of 1 mg/
ml of pronase in PBS, pH 7 .4, at 22 °C for 30 min . There is no
evidence of fibronectin remaining after treatment . Fig . 12 a shows
the section treated with absorbed antifibronectin revealed no stain-
ing . The exposure times for these micrographs were identical . Ap-
propriate controls stained with preimmune rabbit serum after diges-
tion revealed negligible fluorescence . Bar, 25 pm . x 400 .FIGURES 13-15
￿
Effect of hyaluronidase and pronase treatment on frozen sections of articular cartilage from 21-d-old rats stained
for fibronectin . Fig . 13 shows the untreated control . The fibronectin is localized with the chondrocytes (arrows) but absent in the
cartilaginous matrix . The perichondrium is highly reactive for fibronectin . Fig . 14 shows the section treated with 25 ul of 1 mg/ml
testicular hyaluronidase in PBS, pH 7.4, at 22°C for 30 min . Note the unmasking of the fibronectin in the cartilaginous matrix with
this treatment . Fig. 15 shows the section treated with 25 g.l of 1 mg/ml pronase in PBS, pH 7 .4, at 22°C for 30 min . There is no
evidence of fibronectin remaining after pronase treatment . The exposure times for these micrographs were identical . Appropriate
controls stained with preimmune rabbit serum after digestion revealed no background fluorescence . Bar, 25 jam . x 384.
FIGURE 16 Frozen section of epiphyseal growth plate stained for
fibronectin after hyaluronidase digestion . PC, proliferating condro-
cytes ; HC, hypertrophic chondrocytes ; ZM, zone of provisional
mineralization ; BO, bone . Bar, 25 pm . x 400 .
entiate (independently assessed by
35504 incorporation [18,
19]), there was already a significant decrease in fluorescence,
and byday 7, only chondrocytesexhibited fluorescence . Dessau
et al. (4) have shown that dispersed chondrocytes in vitro
synthesize fibronectin . The interaction of fibronectin and pro-
teoglycans has been demonstrated in vitro (10, 17) . Data pre-
sented here also indicate the close relationship between fibro-
nectin and proteoglycans in situ. Dessau et al. (4, 5) reported
that fibronectin was absent in sternal cartilage and embryonic
chick limb bud cartilage . The matrix-induced cartilage system
described in this report appears to be different from the system
described by Dessau et al . (4) in this regard when observed
with hyaluronidase pretreatment, possibly caused by the fact
that, in the present model, cartilage is replaced by bone,
reminiscent of embryonic endochondral bone development .
Alternatively, the difference may be caused by fixation of
tissues in the earlier study (4) .
There has been much speculation about the in vivo role of
fibronectin (7, 9, 11, 16, 22, 27) . This report describes the
appearance of fibronectin during the in vivo development of
bone . Based on the evidence in this report, a possible scheme
for the role of fibronectin is outlined as follows . Initially,
plasma fibronectin binds to the implanted collagenous demin-
eralized bone matrix . This may allow for initial cell attachment
and subsequent recognition of the implanted matrix. It is also
possible that fibronectin may be chemotactic (H . Kleinman,
personal communication); therefore, it may also play a role in
cell recruitment to implant site . When the mesenchymal pre-
cursor cells proliferate, fibronectin is present in a cottony
fibrillar array, described in various cell cultures (2, 8, 25) .
When these cells differentiate into chondrocytes, they still have
their cell-associated fibronectin. During chondrolysis and the
removal of proteoglycans, the fibronectin in the extracellular
matrix is unmasked. This "exposed" fibronectin may support
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￿
Frozen section of spongy bone (untreated) stained for
fibronectin . Note the appearance of osteoblasts with typical cottony
array of fluorescence (arrow) . This localization was not seen in the
spongy bone of Fig . 16 which was digested with hyaluronidase . Bar,
1.25 gm . x 800 .
recruitment and attachment of mesenchymal osteoprogenitor
cells that will soon infiltrate the area and differentiate into
osteoblasts.
Endothelial cells are known to synthesize fibronectin (1, 15)
and it is clear from this study that endosteal surfaces, which
have numerous blood vessels associated with them, are rich in
fibronectin . Fibronectin was also observed in the osteoblasts
and bone, as seen by immunofluorescence localization . Fluo-
rographs confirmed the biosynthesis of fibronectin during os-
teogenesis. It is of interest to note, in contrast to extracellular
matrix fibronectin, that the chondrocyte and osteoblast cell
surface fibronectinswere susceptible to the hyaluronidase treat-
ment . Furthermore, the observation that some fibronectin is
extracted in low salt and some in high salt (e.g ., 4.0M guani-
dine-HCl) may lend additional support to the occurrence of
different pools or classes of tissue fibronectins based on their
extractability and susceptibility to enzymes . Finally, fibronec-
tin in the bone marrow may be a critical element of the
hematopoietic microenvironment .
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In summary, fibronectinwaspresent in developing bone and
was synthesized by mesenchymal cells, chondrocytes, and os-
teoblasts. Fibronectin appears to be a ubiquitous component
of developing skeletal matrix.
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